Fundraising FoxAerie Pharmaceuticals
Bedminster, US · 5 known investors
Find your way into Aerie Pharmaceuticals
Sign up to see every warm intro you have to Aerie Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aerie Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease. The company serves eye care professionals and patients in the global ophthalmic pharmaceutical market.
Founders & leadership
Board
Investors · 5
How we know: Alta Partners's portfolio page · Not right? Tell us
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$125M disclosed across 1 round · 2014
▶$125MraisedSep 2014 · 5 investors · PharmaceuticalsRule 506(b)
- DAVID GRYSKADirector
- VICENTE ANIDOExecutive Officer, Director
- MURRAY GOLDBERGDirector
- ANAND MEHRADirector
- BRIAN LEVYExecutive Officer
- GERALD CAGLEDirector
- CASEY KOPCZYNSKIExecutive Officer
- DENNIS HENNERDirector
- JAMES MAZZODirector
- RICHARD RUBINOExecutive Officer
- GEOFFREY DUYKDirector
- THOMAS MITROExecutive Officer
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Aerie Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- What does Aerie Pharmaceuticals do?
- Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease. The company serves eye care professionals and patients in the global ophthalmic pharmaceutical market.
- Who founded Aerie Pharmaceuticals?
- Aerie Pharmaceuticals was founded by CASEY KOPCZYNSKI.
- Who are Aerie Pharmaceuticals's investors?
- Aerie Pharmaceuticals's investors include Alta Partners, Avoro Capital Advisors, Foresite Capital, OUP (Osage University Partners), Sofinnova Ventures.
- How much funding has Aerie Pharmaceuticals raised?
- Aerie Pharmaceuticals has disclosed $125M raised across 1 round.
- Where is Aerie Pharmaceuticals headquartered?
- Aerie Pharmaceuticals is headquartered in Bedminster, US.